Sep 22 | Mar 22 | Sep 21 | Mar 21 | Sep 20 | |
---|---|---|---|---|---|
Income Statement | - | ||||
Total Revenue | - | - | - | - | - |
Gross Profit | - | - | - | - | - |
EBIT | - | - | - | - | - |
EBITDA | - | - | - | - | - |
Net Income Common Stockholders | - | - | - | - | - |
Balance Sheet | - | ||||
Cash, Cash Equivalents and Short-Term Investments | $ 783.20M | $ 1.21B | $ 975.90M | $ 683.60M | $ 299.10M |
Total Assets | $ 9.60B | $ 9.44B | $ 9.07B | $ 8.64B | $ 8.96B |
Total Debt | $ 3.70B | $ 3.81B | $ 4.01B | $ 4.09B | $ 4.10B |
Net Debt | $ 2.91B | $ 2.60B | $ 3.03B | $ 3.41B | $ 3.80B |
Total Liabilities | $ 6.59B | $ 6.53B | $ 6.54B | $ 6.35B | $ 6.25B |
Stockholders Equity | $ 3.01B | $ 2.91B | $ 2.53B | $ 2.28B | $ 2.71B |
Cash Flow | - | ||||
Free Cash Flow | - | - | - | - | - |
Operating Cash Flow | - | - | - | - | - |
Investing Cash Flow | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - |